Ashland(ASH) - 2024 Q4 - Annual Results

Exhibit 99.1 Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event Financial results for fourth-quarter fiscal 2024 1 • Sales of $522 million, up one percent from the prior-year quarter • Sold nutraceuticals business to Turnspire Capital Partners LLC • Previously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives red ...